Physiology-guided artificial intelligence digital twins for simulating glucose dynamics in type 2 diabetes

IF 4.9 2区 医学 Q1 ENGINEERING, BIOMEDICAL
Biocybernetics and Biomedical Engineering Pub Date : 2026-07-01 Epub Date: 2026-08-22 DOI:10.1016/j.bbe.2026.08.001
Valentina Roquemen-Echeverri, Clara Escorihuela-Altaba, Taisa Kushner, Peter G. Jacobs, Jose Garcia-Tirado, Clara Mosquera-Lopez
{"title":"Physiology-guided artificial intelligence digital twins for simulating glucose dynamics in type 2 diabetes","authors":"Valentina Roquemen-Echeverri,&nbsp;Clara Escorihuela-Altaba,&nbsp;Taisa Kushner,&nbsp;Peter G. Jacobs,&nbsp;Jose Garcia-Tirado,&nbsp;Clara Mosquera-Lopez","doi":"10.1016/j.bbe.2026.08.001","DOIUrl":null,"url":null,"abstract":"<div><div><strong>Background:</strong> Metabolic simulators help accelerate the development of diabetes technologies, but existing mechanistic models for type 2 diabetes (T2D) are difficult to individualize and provide limited explanation of the complex interplay between physiology and available treatments. <strong>Methods:</strong> First, we trained NeuralOGTT, a neural network state-space model that replicates glucose-insulin dynamics during the oral glucose tolerance test (OGTT) in T2D. Next, we determined the minimal model architecture using a variance-based sensitivity analysis. Finally, we created digital twins (DT-NeuralOGTT) by adding auxiliary sub-networks to the NeuralOGTT trained using individuals data from a free-living observational study (N=38, age: 50 ± 10 years; 27 females; 1 high risk of diabetes, 9 pre-T2D, and 28 T2D). We simulated study scenarios and assessed the digital twins ability to replicate real-world glucose outcomes: time in range (TIR,<span><math><mrow><mn>70</mn><mo>−</mo><mn>180</mn></mrow></math></span> mg/dL), time in tight range (TITR,<span><math><mrow><mn>70</mn><mo>−</mo><mn>140</mn></mrow></math></span> mg/dL), time below range (TBR, &lt; 70 mg/dL), and time above range (TAR, &gt; 180 mg/dL). <strong>Results:</strong> NeuralOGTT replicated glucose dynamics during OGTTs. Personalized DT-NeuralOGTT enabled generalization under free-living conditions across 12-h simulations, achieving simulated glucose outcomes that are statistically identical to observed outcomes: TIR: 91.8 (95% CI:82.2–96.0)% vs. 92.1 (95% CI:83.5–95.8)%, TITR: 56.0 (95% CI:36.6–77.4)% vs. 59.3 (95% CI:48.7–76.4)%, TAR: 6.3 (95% CI:1.6–15.8)% vs. 7.4 (95% CI:3.8–15.7)%, and TBR: 0.5 (95% CI:0.0–1.0)% vs. 0.1 (95% CI:0.1–0.2)%. <strong>Conclusion:</strong> NeuralOGTT models glucose–insulin dynamics using a structure that preserves explainability while requiring small amounts of training data. DT-NeuralOGTT incorporates individual variability to better capture dynamics in pre-T2D and T2D. Code available: <span><span>https://github.com/mosqueralopez/T2DSim_AI</span><svg><path></path></svg></span></div></div>","PeriodicalId":55381,"journal":{"name":"Biocybernetics and Biomedical Engineering","volume":"46 3","pages":"Pages 619-635"},"PeriodicalIF":4.9000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biocybernetics and Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0208521626000562","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Metabolic simulators help accelerate the development of diabetes technologies, but existing mechanistic models for type 2 diabetes (T2D) are difficult to individualize and provide limited explanation of the complex interplay between physiology and available treatments. Methods: First, we trained NeuralOGTT, a neural network state-space model that replicates glucose-insulin dynamics during the oral glucose tolerance test (OGTT) in T2D. Next, we determined the minimal model architecture using a variance-based sensitivity analysis. Finally, we created digital twins (DT-NeuralOGTT) by adding auxiliary sub-networks to the NeuralOGTT trained using individuals data from a free-living observational study (N=38, age: 50 ± 10 years; 27 females; 1 high risk of diabetes, 9 pre-T2D, and 28 T2D). We simulated study scenarios and assessed the digital twins ability to replicate real-world glucose outcomes: time in range (TIR,70−180 mg/dL), time in tight range (TITR,70−140 mg/dL), time below range (TBR, < 70 mg/dL), and time above range (TAR, > 180 mg/dL). Results: NeuralOGTT replicated glucose dynamics during OGTTs. Personalized DT-NeuralOGTT enabled generalization under free-living conditions across 12-h simulations, achieving simulated glucose outcomes that are statistically identical to observed outcomes: TIR: 91.8 (95% CI:82.2–96.0)% vs. 92.1 (95% CI:83.5–95.8)%, TITR: 56.0 (95% CI:36.6–77.4)% vs. 59.3 (95% CI:48.7–76.4)%, TAR: 6.3 (95% CI:1.6–15.8)% vs. 7.4 (95% CI:3.8–15.7)%, and TBR: 0.5 (95% CI:0.0–1.0)% vs. 0.1 (95% CI:0.1–0.2)%. Conclusion: NeuralOGTT models glucose–insulin dynamics using a structure that preserves explainability while requiring small amounts of training data. DT-NeuralOGTT incorporates individual variability to better capture dynamics in pre-T2D and T2D. Code available: https://github.com/mosqueralopez/T2DSim_AI
模拟2型糖尿病血糖动态的生理引导人工智能数字双胞胎
背景:代谢模拟器有助于加速糖尿病技术的发展,但现有的2型糖尿病(T2D)的机制模型难以个体化,并且对生理和现有治疗之间复杂的相互作用提供有限的解释。方法:首先,我们训练了神经网络状态空间模型NeuralOGTT,该模型在t2dm患者口服葡萄糖耐量试验(OGTT)期间复制葡萄糖-胰岛素动态。接下来,我们使用基于方差的灵敏度分析确定最小模型架构。最后,我们创建了数字双胞胎(DT-NeuralOGTT),通过将辅助子网络添加到使用自由生活观察性研究个体数据训练的NeuralOGTT中(N=38,年龄:50 ± 10岁;27名女性;1名糖尿病高危患者,9名T2D前期患者,28名T2D患者)。我们模拟了研究场景并评估了数字双胞胎复制真实血糖结果的能力:在范围内的时间(TIR,70 - 180 mg/dL),在窄范围内的时间(TITR,70 - 140 mg/dL),在范围以下的时间(TBR, <; 70 mg/dL),以及在范围以上的时间(TAR, >; 180 mg/dL)。结果:NeuralOGTT在ogtt期间复制了葡萄糖动力学。个性化DT-NeuralOGTT在自由生活条件下进行了12小时的模拟,实现了与观察结果统计上相同的模拟血糖结果:TIR: 91.8 (95% CI: 82.2-96.0)% vs. 92.1 (95% CI: 83.5-95.8)%, TITR: 56.0 (95% CI: 36.6-77.4)% vs. 59.3 (95% CI: 48.7-76.4)%, TAR: 6.3 (95% CI: 1.6-15.8)% vs. 7.4 (95% CI: 3.8-15.7)%, TBR: 0.5 (95% CI: 0.0-1.0)% vs. 0.1 (95% CI:0.1 - 0.2)%。结论:NeuralOGTT模型使用的结构保留了可解释性,同时需要少量的训练数据。DT-NeuralOGTT结合了个体差异,以更好地捕捉T2D前和T2D的动态。可用代码:https://github.com/mosqueralopez/T2DSim_AI
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
16.50
自引率
6.20%
发文量
77
审稿时长
38 days
期刊介绍: Biocybernetics and Biomedical Engineering is a quarterly journal, founded in 1981, devoted to publishing the results of original, innovative and creative research investigations in the field of Biocybernetics and biomedical engineering, which bridges mathematical, physical, chemical and engineering methods and technology to analyse physiological processes in living organisms as well as to develop methods, devices and systems used in biology and medicine, mainly in medical diagnosis, monitoring systems and therapy. The Journal''s mission is to advance scientific discovery into new or improved standards of care, and promotion a wide-ranging exchange between science and its application to humans.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书